HEPTROMIC

Genomic predictors and oncogenic drivers in hepatocellular carcinoma.
will optimise decision-making for liver cancer patients by identifying genomic prognostic determinants and oncogenic drivers.
’s core team comprises leading European researchers in the basic, translational and clinical fields of liver cancer.
is a 3-year translational research project which aims to solve core problems in the management of hepatocellular carcinoma (HCC), the third most common cause of cancer-related death worldwide.

News

Prof Llovet invited to participate at the EU Grant Session at EASL

Prof Llovet was invited to participate as speaker at the EU Grant Session: “Improving Liver Research Funding from the EU” which was held on Friday, April 1, 2011 during the International Liver Congress by EASL in Berlin, Germany from March 30th – April 3rd, 2011.

This new initiative aimed to promote and exchange the numerous programmes, projects and support that are carried out at EU level. Prof Llovet gave a talk that presented his experience as Principal Investigator within a European project and explained how is the Heptromic Project the first European Research project centred specifically on the genomics of this type of cancer.
Watch the HEPTROMIC video

The HEPTROMIC video was presented during the kick-off meeting of the Project, which took place yesterday in Barcelona. Its main objective is to explain the goals and the project and the outstanding team that will make it possible.